Keyphrases
ALS Functional Rating Scale
14%
Amyotrophic Lateral Sclerosis
100%
Amyotrophic Lateral Sclerosis Functional Rating Scale-revised
14%
Bone Marrow
14%
Bone Marrow Mononuclear Cells
14%
CD34+
28%
Cell Subsets
14%
Compound muscle Action Potential Amplitude
14%
Disease Deterioration
14%
Disease Progression
28%
Functional Decline
14%
Granulocyte Colony-stimulating Factor (G-CSF)
100%
Hematopoietic Stem Cells
14%
Item Quality
14%
Lower Slope
14%
Muscle Strength
14%
Neurophysiological Index
14%
Peripheral Blood
14%
Placebo
28%
Primary Outcome Measure
14%
Quality of Life Assessment
28%
Quality Rating
14%
Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
100%
Revised Amyotrophic Lateral Sclerosis Functional Rating Scale
14%
Significant Benefit
14%
Slowing down
14%
Vital Capacity
14%
Medicine and Dentistry
Action Potential Amplitude
14%
Amyotrophic Lateral Sclerosis
100%
Bone Marrow Cell
14%
Compound Muscle Action Potential
14%
Deterioration
14%
Disease Exacerbation
28%
Down Syndrome
28%
Granulocyte Colony Stimulating Factor
100%
Hematopoietic Cell
14%
Muscle Strength
14%
Placebo
28%
Quality of Life
28%
Rating Scale
28%
Recombinant Granulocyte Colony Stimulating Factor
100%
Side Effect
14%
Vital Capacity
14%
Neuroscience
Action Potential
14%
Amyotrophic Lateral Sclerosis
100%
CD34
28%
Down Syndrome
28%
Granulocyte Colony-Stimulating Factor
100%
Hematopoietic Cell
14%
Placebo
28%
Recombinant Granulocyte Colony Stimulating Factor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Deterioration
14%
Disease Exacerbation
28%
Down Syndrome
28%
Granulocyte Colony Stimulating Factor
100%
Placebo
28%
Recombinant Granulocyte Colony Stimulating Factor
100%
Side Effect
14%
Immunology and Microbiology
Action Potential Amplitude
14%
Bone Marrow Cell
14%
CD34
28%
Granulocyte Colony-Stimulating Factor
100%
Hematopoietic Cell
14%
Muscle Action Potential
14%
Muscle Strength
14%
Recombinant Granulocyte Colony Stimulating Factor
100%
Vital Capacity
14%